Right to IVF Act of 2026 Mandates National Fertility Rights and Expands Coverage for Veterans and Medicaid Recipients by 2027

The Right to IVF Act of 2026 establishes a federal right for individuals to access assisted reproductive technology (ART), such as IVF and intrauterine insemination (IUI), effectively overriding state-level restrictions that create 'unjustified barriers' to these services. Beyond just legalizing the procedures, the bill forces a massive shift in how we pay for them: starting in 2027, it mandates coverage for ART and IUI across Medicare Part B, state Medicaid programs, and the Federal Employees Health Benefits (FEHB) program. It also requires private employer-sponsored plans to cover these treatments without hitting patients with higher out-of-pocket costs than they’d pay for any other medical service.

Family Planning for Those Who Serve

For military families, this bill is a major game-changer. Title II requires the Department of Defense and the VA to provide comprehensive fertility treatments—including up to three egg retrievals and unlimited embryo transfers—to active-duty members, veterans, and their partners. This isn't just about the procedure itself; it includes a 'fertility preservation' mandate. If a service member is being deployed to a zone with hazardous chemical exposure (like PFAS) or faces a high risk of injury, the military will now cover the cost of freezing and storing their eggs or sperm. This means a 22-year-old soldier can protect their future ability to have a family before heading into harm's way, with the government picking up the tab for storage until a year after they leave the service.

Cutting the Red Tape and the Price Tag

The bill tackles the 'infertility' loophole that many insurance companies use to deny claims. Under Title III, health plans cannot require a formal infertility diagnosis before covering ART or IUI if a doctor deems the treatment appropriate. This is huge for single parents or LGBTQ+ couples who previously had to pay entirely out-of-pocket because they didn't meet a specific clinical definition of infertility. For a teacher on a state insurance plan or a retail worker on Medicaid, this shifts IVF from a luxury costing $20,000 per cycle to a standard medical benefit with predictable co-pays. Medicare beneficiaries also see a significant win: Title III adds these services to Part B with zero coinsurance or deductibles starting in January 2027.

The Legal and Financial Landscape

While the bill is a massive win for access, it sets up a high-stakes legal tug-of-war. By explicitly preempting state laws (Title I), the federal government is drawing a line in the sand against states that have attempted to restrict embryo handling or freezing. The bill gives the Attorney General the power to sue states that step out of line, which almost guarantees a wave of litigation. On the financial side, while the bill prevents insurers from price-gouging patients, the expansion of benefits to millions of people via Medicaid and Medicare will undoubtedly increase federal spending. For the average person, the trade-off is clear: more legal certainty and lower personal costs for family building, balanced against the broader economic reality of expanded government-funded healthcare.